Director and Consulting Radiologist
Dr Pradnya Dugal is a dual radiology gold medallist. Dr Dugal trained through Royal Prince Alfred Hospital, Sydney, and has fellowship experience at New York University and Thomas Jefferson University in the USA, particularly in cardiac and musculoskeletal imaging, as well as an interest in women’s imaging.
Consulting Research Director and Consulting Neurologist
Prof. Michael Barnett is a consultant neurologist at Royal Prince Alfred Hospital Sydney, Professor in Neurology at the University of Sydney, and Director of the MS Society clinic and MS Clinical Trials Unit at the Brain and Mind Centre. He trained in neurology at Royal Prince Alfred Hospital and received further subspecialty training at the National Hospital for Neurology and Neurosurgery in London. He subsequently completed a PhD in MS pathophysiology at the University of Sydney. Dr Barnett’s current research focus is neuroimaging applications in MS, and in in 2012 he co-founded the Sydney Neuroimaging Analysis Centre. He is Director of the MS Research Australia Brain Bank, is a member of the Australian MS Clinical Trials Network Scientific Committee, and is a council member to the Nerve Research Foundation, University of Sydney.
Director of Operations
Dr. Chenyu (Tim) Wang is a postdoctoral researcher at Brain and Mind Centre and the Director of Operations at Sydney Neuroimaging Analysis Centre. With a background in electronics & information engineering and neuroimaging, Dr. Wang has particular research interests in the development of novel MRI and electrophysiological biomarkers of myelin and axonal integrity in neurological disorders, particularly for sub-clinical disease progression.
Dr Yael Barnett is a specialist neuroradiologist and the Director of MRI at St Vincent’s Hospital (Sydney). She undertook advanced training in Radiology at Royal North Shore Hospital (Sydney) and subsequently a speciality fellowship in Neuroradiology at the Brain and Mind Centre and Royal North Shore Hospital. Dr Barnett has particular interest and expertise in the imaging of multiple sclerosis, both from a clinical and translational research perspective.
Senior Project Manager and Biotechnologist
Dr Linda Ly joined SNAC in 2013, following completion of her postdoctoral studies, which focussed on the proteomic analysis of postmortem multiple sclerosis tissue. She completed her PhD in Biotechnology at the University of NSW, and postdoctoral research at the University of Sydney. Linda’s expertise in neuropathology, and in particular the characterisation of MS tissue, has added a critical dimension to the SNAC team. In 2012, she shifted her research focus to neuroimaging, and is now responsible for the implementation of conventional/structural image analysis pipelines, and databasing, across the SNAC research portfolio.
Consulting Clinical Trials Coordinator
Marinda started her research career in 1995 at the University of Witwatersrand and University of Johannesburg studying Academic and Clinical Trials Research. She acquired a PhD in 2000 in Midwifery and Neonatology from the University of Johannesburg. In 2009 Marinda joined the MS Clinical Trials Unit at the Brain and Mind Research Institute (University of Sydney) and became the Trial Coordinator in 2010. Marinda currently manages over ten clinical and investigator trials and is involved with the MS Research Australia Brain Bank.
Kain completed a Bachelor of Science at the University of Western Australia, majoring in Physics and Chemistry. He proceeded to commence a Masters in MRI Technology through the University of Queensland, where his Master’s project is investigating the changes in brain metabolite concentrations in multiple sclerosis using Magnetic Resonance Spectroscopy.
Libo is a project manager at SNAC, with over a decade of experience in software development and project management. He has strong interests in data analytics and the applications of deep learning. He holds a Master of Science from Shanghai Jiaotong University, majoring in Control Theory and Engineering, and recently obtained a Master of Data Science from the University of Sydney. Before joining SNAC, Libo led multiple new product development projects to commercial launch for Danaher Corporation, a global science and technology company.
Chief Software Architect
Dr Andy Shieh leads the software development team at SNAC that develops and deploys medical imaging and AI technologies in the clinics. He completed his PhD at the University of Sydney focusing on innovative medical imaging algorithms. He has a strong background in computer science, mathematics, and physics.
Dr. Kaushik Ram finished his PhD at Westmead Hospital, University of Sydney where he specialised in neuroimaging. Here, he was the central figure in the MRI arm of the Emotional Wellbeing Project developing neuroimaging biomarkers for the prediction of psychiatric disorders. He has now shifted his focus to degenerative neurological conditions. He joins the team at SNAC to apply his expertise in clinical trials, research and development of neuroimaging pipelines, particularly for multiple sclerosis.
Clinical Research Officer
Suzie graduated with a Bachelor of Science majoring in psychology and neuroscience, and went on to complete a Master of Nutrition and Dietetics, both from the University of Sydney. As Clinical Research Officer, she coordinates the day to day clinical trial operations at SNAC.
Consulting Ophthalmic Scientist
A/Prof Klistorner is leading neuroimaging and electrophysiology research in ophthalmology departments of both Sydney and Macquarie universities. After completing his PhD in UNSW he joining Sydney University in 1997 he established a laboratory of clinical electrophysiology. His main focus of research was the visual system and its role as a model to study pathophysiology of neurodegenerative diseases. In collaboration with Prof S. Graham he developed and patented clinical application of multifocal Visual Evoked Potentials (mfVEP). His close collaboration with Hebrew University (Israel) resulted in implementation of a new methodology to analyze the posterior part of the visual pathway and subsequently led to his research of optic radiation, producing new methodology for longitudinal analysis of diffusivity metrics in individual MS lesions. Moreover, the group under his leadership demonstrated for the first time the role of demyelination in trans-synaptic neurodegeneration, broadening the potential applicability of remyelination therapy. A/Prof Klistorner’s research has led to 114 publications (57 as first or senior author) (h-index 34).